Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 14.2% beneficial ownership stake in PJT Partners Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 7.3% beneficial ownership stake in Quanterix Corp's common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.1% beneficial ownership stake in Enliven Therapeutics Inc., held in the ordinary course of business.

BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a 7.0% beneficial ownership stake in EPAM Systems Inc. common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting a 6.5% beneficial ownership stake in Eos Energy Enterprises, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, disclosing a 12.5% beneficial ownership stake in Vestis Corp's common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, disclosing a 4.5% beneficial ownership stake in First Citizens BancShares, Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.9% of First Community Bankshares Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.1% beneficial ownership stake in Fortune Brands Innovations, Inc. as a passive investor.

BlackRock, Inc. has reported a beneficial ownership of 15.3% in Fortrea Holdings Inc., holding 13,807,176 shares of common stock.

BlackRock, Inc. has reported a beneficial ownership of 15.9% of Franklin BSP Realty Trust, Inc.'s common stock, totaling 13,092,272 shares, as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.0% beneficial ownership stake in T1 Energy Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting a 2.1% passive beneficial ownership stake in FuelCell Energy Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.7% beneficial ownership stake in FTAI Infrastructure Inc. as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a 6.1% beneficial ownership stake in GCM Grosvenor Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 2.7% beneficial ownership stake in Geospace Technologies Corporation as of June 30, 2025.

BlackRock, Inc. has disclosed a 6.5% beneficial ownership stake in Ginkgo Bioworks Holdings, Inc., holding over 3 million shares of common stock.

BlackRock, Inc. filed an Amendment No. 9 to its Schedule 13G, disclosing a 2.1% beneficial ownership stake in GoPro Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 14.4% in Grocery Outlet Holding Corp.'s common stock as of June 30, 2025.

BlackRock, Inc. has reported a beneficial ownership of 16.3% of Insteel Industries Inc.'s common stock, holding 3,172,177 shares as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.1% beneficial ownership stake in Inozyme Pharma Inc. as of June 30, 2025.

BlackRock, Inc. has reported a passive beneficial ownership of 5.6% of KULR Technology Group, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.5% passive beneficial ownership stake in LegalZoom.com Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G disclosing a 1.0% beneficial ownership in Lineage Cell Therapeutics Inc. common stock, while also noting that a subsidiary, BlackRock Institutional Trust Company, National Association, holds 5% or more.

BlackRock, Inc. has reported a 7.1% beneficial ownership stake in Magnera Corp's common stock as of June 30, 2025.

BlackRock, Inc. has reported an 11.1% beneficial ownership stake in Marriott Vacations Worldwide Corp. common stock as of June 30, 2025, holding 3,837,136 shares.

BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, reporting beneficial ownership of 3.0% of Mersana Therapeutics Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, revealing a beneficial ownership of 13.2% of Capitol Federal Financial Inc.'s Common Stock.

BlackRock, Inc. has reported a 7.2% beneficial ownership stake in Clover Health Investments Corp. CLA, holding over 29.8 million shares as of June 30, 2025.

BlackRock, Inc. has reported a 5.8% beneficial ownership stake in Day One Biopharmaceuticals, Inc., holding 5,849,917 shares of common stock.